IA
ABBV icon

Insight Advisors’s AbbVie ABBV Stock Holding History

Insight Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$578K Sell
2,295
-20
-0.9% -$4.3K 0.1% 131
2026
Q1 		$503K Buy
2,315
+21
+0.9% +$4.66K 0.1% 138
2025
Q4 		$524K Sell
2,294
-64
-3% -$14.6K 0.08% 155
2025
Q3 		$546K Sell
2,358
-85
-3% -$17.3K 0.08% 151
2025
Q2 		$453K Sell
2,443
-9
-0.4% -$1.67K 0.07% 165
2025
Q1 		$514K Buy
2,452
+27
+1% +$5.25K 0.09% 142
2024
Q4 		$427K Sell
2,425
-66
-3% -$12.1K 0.07% 179
2024
Q3 		$492K Buy
2,491
+16
+0.6% +$2.99K 0.08% 165
2024
Q2 		$424K Buy
2,475
+148
+6% +$24.5K 0.08% 179
2024
Q1 		$424K Buy
2,327
+7
+0.3% +$1.21K 0.08% 179
2023
Q4 		$360K Sell
2,320
-222
-9% -$32.4K 0.08% 188
2023
Q3 		$379K Buy
2,542
+53
+2% +$7.78K 0.09% 174
2023
Q2 		$335K Buy
2,489
+394
+19% +$57.8K 0.07% 195
2023
Q1 		$334K Sell
2,095
-752
-26% -$115K 0.08% 206
2022
Q4 		$462K Sell
2,847
-1,654
-37% -$254K 0.16% 171
2022
Q3 		$604K Sell
4,501
-8
-0.2% -$1.15K 0.24% 109
2022
Q2 		$634K Sell
4,509
-1,708
-27% -$261K 0.22% 121
2022
Q1 		$1.01M Buy
6,217
+2,373
+62% +$345K 0.3% 93
2021
Q4 		$520K Buy
3,844
+1,813
+89% +$214K 0.15% 167
2021
Q3 		$238K Sell
2,031
-11
-0.5% -$1.26K 0.07% 276
2021
Q2 		$236K Sell
2,042
-522
-20% -$58.8K 0.07% 276
2021
Q1 		$287K Buy
2,564
+375
+17% +$40.1K 0.09% 266
2020
Q4 		$235K Buy
+2,189
New +$210K 0.09% 239

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Insight Advisors's ABBV Position: Q2 2026 in Review

Insight Advisors reduced its AbbVie (ABBV) stake by 0.86% in Q2 2026, selling an estimated $4.3K and leaving 2,295 shares worth $578K. The position accounts for 0.1% of the portfolio, ranked #131.

Insight Advisors first reported a position in ABBV in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.01M in Q1 2022. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Insight Advisors held 2,295 shares of AbbVie worth $578K as of Q2 2026.
  • Insight Advisors sold 20 AbbVie shares in Q2 2026, an estimated $4.3K.
  • AbbVie made up 0.1% of Insight Advisors's portfolio in Q2 2026, its #131 holding.
  • Insight Advisors first reported a position in AbbVie in Q4 2020 and has held it in 23 quarters since.
  • Insight Advisors's AbbVie position peaked at $1.01M in Q1 2022.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Insight Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.